Q&A: Former FDA Coronary Device Officer Hops To Gore
Executive Summary
Former US FDA cardiac device medical officer John Laschinger spoke to Medtech Insight about his work at the agency and his move to device-maker W.L. Gore & Associates as cardiac chief medical advisor.
You may also be interested in...
FDA Works To Connect Cardiac Device Registries
US FDA is working with manufacturers, researchers and other stakeholders to assemble a comprehensive network of registries of cardiac device data. But cardiologists and device firms say the project faces multiple challenges.
Addition to Quest Alzheimer's Suite Looks For Biomarker P-Tau217
The test is being integrated into Quest’s AD-Detect portfolio for assessing the risk of Alzheimer’s. It is the third p-tau217 test to make news this month, after new breakthrough designations for Quanterix and Roche and Eli Lilly.
‘Core Pillars’ Of Safety And Innovation Take Center Stage In FDA Reports
The US FDA has issued a pair of reports focused on device safety and innovation. The reports describe recent steps the agency has taken to improve in the two areas, and what it plans to do next.